Filter News
Area of Research
- (-) National Security (28)
- (-) Neutron Science (82)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Biology and Environment (108)
- Biology and Soft Matter (1)
- Clean Energy (111)
- Climate and Environmental Systems (2)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (6)
- Isotopes (2)
- Materials (73)
- Materials for Computing (10)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (77)
News Type
News Topics
- (-) Bioenergy (8)
- (-) Energy Storage (5)
- (-) Environment (10)
- (-) Machine Learning (15)
- (-) Neutron Science (74)
- (-) Security (11)
- (-) Summit (6)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (1)
- Artificial Intelligence (17)
- Big Data (6)
- Biology (9)
- Biomedical (11)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (5)
- Composites (1)
- Computer Science (29)
- Coronavirus (9)
- Cybersecurity (17)
- Decarbonization (4)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (2)
- Fusion (2)
- Grid (4)
- High-Performance Computing (6)
- Materials (13)
- Materials Science (21)
- Mathematics (1)
- Microscopy (2)
- Nanotechnology (9)
- National Security (34)
- Nuclear Energy (5)
- Partnerships (4)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (6)
- Simulation (1)
- Space Exploration (2)
- Sustainable Energy (3)
- Transportation (5)
Media Contacts
Two of the researchers who share the Nobel Prize in Chemistry announced Wednesday—John B. Goodenough of the University of Texas at Austin and M. Stanley Whittingham of Binghamton University in New York—have research ties to ORNL.
Using the Titan supercomputer and the Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory, scientists have created the most accurate 3D model yet of an intrinsically disordered protein, revealing the ensemble of its atomic-level structures.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Collaborators at the Department of Energy’s Oak Ridge National Laboratory and U.S. universities used neutron scattering and other advanced characterization techniques to study how a prominent catalyst enables the “water-gas shift” reaction to purify and generate hydrogen at industrial scale.
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
Tempering, the heating process that gives chocolate its appealing sheen and creamy texture, is a crucial part of crafting quality chocolate. But, at the molecular level, it gets a little tricky, and when done incorrectly, can render entire batches of chocolate gritty and unappetizing.
OAK RIDGE, Tenn., May 14, 2019—Advanced Research Systems, Inc., has licensed a technology designed to automatically refill liquid helium used in laboratory equipment for low-temperature scientific experiments, which will reduce downtime, recover more helium and increase overall efficiency.
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
Ionic conduction involves the movement of ions from one location to another inside a material. The ions travel through point defects, which are irregularities in the otherwise consistent arrangement of atoms known as the crystal lattice. This sometimes sluggish process can limit the performance and efficiency of fuel cells, batteries, and other energy storage technologies.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.